| SpectraBase Spectrum ID |
5YxAi7K8u8G |
| Name |
1-(3,4-Methylenedioxybenzyl)-4-(3-trifluoromethylbenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
378.155512411 u |
| Formula |
C20H21F3N2O2 |
| InChI |
InChI=1S/C20H21F3N2O2/c21-20(22,23)17-3-1-2-15(10-17)12-24-6-8-25(9-7-24)13-16-4-5-18-19(11-16)27-14-26-18/h1-5,10-11H,6-9,12-14H2 |
| InChIKey |
VMZWCXCYGWLQFH-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
378.395 g/mol |
| Nominal Mass |
378 u |
| Quality |
979 |
| Retention Index |
2475 |
| SMILES |
C1=2C(=CC=C(C2)CN2CCN(CC=3C=C(C(F)(F)F)C=CC3)CC2)OCO1 |
| SPLASH |
splash10-0a4r-4920000000-1afdc6a9d87ed86f017f |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(3,4-methylenedioxybenzyl)-4-(3-trifluoromethylbenzyl)
1-(1,3-benzodioxol-5-ylmethyl)-4-(3-(trifluoromethyl)benzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011267 |
